TrialGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2021

Docetaxel plus S-1 versus cisplatin plus S-1 in unresectable gastric cancer without measurable lesions: a randomized phase II trial (HERBIS-3).

Yukinori Kurokawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.